AstraZeneca
- Business
Drug companies face COVID cliff in 2023 as sales set to plummet
Pharmaceutical companies that made billions from the pandemic over the past two years selling vaccines and treatments are now up…
Read More » - Business
European shares edge higher on healthcare lift, weak China data stokes worries
AstraZeneca jumps on positive cancer drug updateChina-exposed automakers, miners lead lossesHelloFresh surges after confirming 2025 target European shares hovered near…
Read More » - Turkiye
EU delays COVID-19 vaccination plan by 3 months
Head of European Commission admits bloc was late to authorize vaccines, too optimistic on manufacturing timelines The European Union has…
Read More » - Business
AstraZeneca buying drug developer Alexion for $39 billion
“This acquisition allows us to enhance our presence in immunology,” AstraZeneca CEO Pascal Soriot said in a statement. Pharmaceutical company…
Read More » - Turkiye
Oxford COVID-19 vaccine prompts immune response among adults old and young, AstraZeneca says
The COVID-19 vaccine being developed by the University of Oxford produces a similar immune response in both older and younger…
Read More » - Turkiye
AstraZeneca agrees to supply Europe with 400 million doses of COVID-19 vaccine
AstraZeneca Plc has signed a contract with European governments to supply the region with its potential vaccine against the coronavirus,…
Read More » - Turkiye
AstraZeneca says it can produce 1 billion doses of Oxford’s potential COVID-19 vaccine
AstraZeneca AZN, -0.10% AZN, +0.39% said it’s taking steps to make the University of Oxford’s COVID-19 vaccine widely accessible around…
Read More »